PreveCeutical Medical (TSE:PREV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PreveCeutical Medical’s subsidiary, BioGene Therapeutics, has appointed Dr. Mariya Georgieva as President to lead advancements in siRNA therapy for diabetes and obesity. Dr. Georgieva brings valuable experience from AstraZeneca, enhancing BioGene’s research capabilities in metabolic health and gene-based treatments.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.